US Stock MarketDetailed Quotes

EVOK Evoke Pharma

Watchlist
  • 2.350
  • +0.100+4.44%
Close Apr 7 16:00 ET
3.51MMarket Cap-0.84P/E (TTM)

Evoke Pharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
97.84%10.25M
97.40%3.31M
69.83%2.65M
125.51%2.55M
114.15%1.74M
106.51%5.18M
110.45%1.68M
87.82%1.56M
144.99%1.13M
93.70%810.41K
Operating revenue
97.84%10.25M
97.40%3.31M
69.83%2.65M
125.51%2.55M
114.15%1.74M
106.51%5.18M
110.45%1.68M
87.82%1.56M
144.99%1.13M
93.70%810.41K
Cost of revenue
76.61%356.53K
100.77%118.5K
197.99%104.02K
-27.68%41.48K
82.90%92.53K
-45.50%201.88K
-68.95%59.02K
-61.12%34.91K
-15.37%57.36K
122.28%50.59K
Gross profit
98.70%9.89M
97.27%3.19M
66.90%2.55M
133.69%2.51M
116.23%1.64M
132.84%4.98M
166.70%1.62M
105.83%1.53M
172.58%1.07M
92.06%759.82K
Operating expense
21.66%15.1M
25.07%4.38M
22.50%3.84M
30.61%3.73M
7.86%3.14M
25.04%12.41M
51.33%3.5M
17.95%3.13M
14.03%2.86M
19.13%2.91M
Selling and administrative expenses
23.33%15.08M
25.88%4.38M
22.12%3.82M
34.97%3.73M
10.24%3.14M
27.06%12.23M
52.14%3.48M
19.77%3.13M
19.48%2.77M
18.41%2.85M
Research and development costs
-91.03%16.32K
--0
--11.68K
--0
-93.07%4.65K
-39.52%181.91K
-17.08%22.56K
--0
-51.77%92.36K
60.58%66.99K
Operating profit
29.97%-5.2M
36.77%-1.19M
19.82%-1.29M
31.43%-1.22M
30.34%-1.5M
4.56%-7.43M
-10.42%-1.89M
16.16%-1.6M
15.54%-1.78M
-5.07%-2.16M
Net non-operating interest income expense
59.03%-148.06K
100.94%932
70.45%-26.73K
47.71%-43.66K
10.64%-78.6K
17.49%-361.4K
-6.47%-99.48K
10.70%-90.47K
30.85%-83.49K
28.19%-87.96K
Non-operating interest income
154.92%353.31K
378.30%126.96K
179.25%99.29K
96.78%81K
30.36%46.06K
123.52%138.6K
-18.55%26.54K
43.88%35.56K
952.79%41.16K
4,344.15%35.33K
Non-operating interest expense
0.27%501.37K
0.00%126.03K
-0.00%126.03K
-0.00%124.66K
1.11%124.66K
0.00%500K
0.00%126.03K
0.00%126.03K
0.00%124.66K
0.00%123.29K
Other net income (expense)
Income before tax
31.31%-5.35M
39.98%-1.19M
22.52%-1.31M
32.16%-1.27M
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
Income tax
Net income
31.31%-5.35M
39.98%-1.19M
22.52%-1.31M
32.16%-1.27M
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
Net income continuous Operations
31.31%-5.35M
39.98%-1.19M
22.52%-1.31M
32.16%-1.27M
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
Minority interest income
Net income attributable to the parent company
31.31%-5.35M
39.98%-1.19M
22.52%-1.31M
32.16%-1.27M
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
31.31%-5.35M
39.98%-1.19M
22.52%-1.31M
32.16%-1.27M
29.57%-1.58M
5.25%-7.79M
-10.21%-1.99M
15.89%-1.69M
16.36%-1.87M
-3.19%-2.24M
Basic earnings per share
89.95%-2.81
88.74%-0.8027
84.54%-0.94
86.14%-0.93
74.63%-2.04
11.04%-27.97
-12.11%-7.13
15.56%-6.08
21.24%-6.71
16.25%-8.04
Diluted earnings per share
89.95%-2.81
88.74%-0.8027
84.54%-0.94
86.14%-0.93
74.63%-2.04
11.04%-27.97
-12.11%-7.13
15.56%-6.08
21.24%-6.71
16.25%-8.04
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 97.84%10.25M97.40%3.31M69.83%2.65M125.51%2.55M114.15%1.74M106.51%5.18M110.45%1.68M87.82%1.56M144.99%1.13M93.70%810.41K
Operating revenue 97.84%10.25M97.40%3.31M69.83%2.65M125.51%2.55M114.15%1.74M106.51%5.18M110.45%1.68M87.82%1.56M144.99%1.13M93.70%810.41K
Cost of revenue 76.61%356.53K100.77%118.5K197.99%104.02K-27.68%41.48K82.90%92.53K-45.50%201.88K-68.95%59.02K-61.12%34.91K-15.37%57.36K122.28%50.59K
Gross profit 98.70%9.89M97.27%3.19M66.90%2.55M133.69%2.51M116.23%1.64M132.84%4.98M166.70%1.62M105.83%1.53M172.58%1.07M92.06%759.82K
Operating expense 21.66%15.1M25.07%4.38M22.50%3.84M30.61%3.73M7.86%3.14M25.04%12.41M51.33%3.5M17.95%3.13M14.03%2.86M19.13%2.91M
Selling and administrative expenses 23.33%15.08M25.88%4.38M22.12%3.82M34.97%3.73M10.24%3.14M27.06%12.23M52.14%3.48M19.77%3.13M19.48%2.77M18.41%2.85M
Research and development costs -91.03%16.32K--0--11.68K--0-93.07%4.65K-39.52%181.91K-17.08%22.56K--0-51.77%92.36K60.58%66.99K
Operating profit 29.97%-5.2M36.77%-1.19M19.82%-1.29M31.43%-1.22M30.34%-1.5M4.56%-7.43M-10.42%-1.89M16.16%-1.6M15.54%-1.78M-5.07%-2.16M
Net non-operating interest income expense 59.03%-148.06K100.94%93270.45%-26.73K47.71%-43.66K10.64%-78.6K17.49%-361.4K-6.47%-99.48K10.70%-90.47K30.85%-83.49K28.19%-87.96K
Non-operating interest income 154.92%353.31K378.30%126.96K179.25%99.29K96.78%81K30.36%46.06K123.52%138.6K-18.55%26.54K43.88%35.56K952.79%41.16K4,344.15%35.33K
Non-operating interest expense 0.27%501.37K0.00%126.03K-0.00%126.03K-0.00%124.66K1.11%124.66K0.00%500K0.00%126.03K0.00%126.03K0.00%124.66K0.00%123.29K
Other net income (expense)
Income before tax 31.31%-5.35M39.98%-1.19M22.52%-1.31M32.16%-1.27M29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M
Income tax
Net income 31.31%-5.35M39.98%-1.19M22.52%-1.31M32.16%-1.27M29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M
Net income continuous Operations 31.31%-5.35M39.98%-1.19M22.52%-1.31M32.16%-1.27M29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M
Minority interest income
Net income attributable to the parent company 31.31%-5.35M39.98%-1.19M22.52%-1.31M32.16%-1.27M29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 31.31%-5.35M39.98%-1.19M22.52%-1.31M32.16%-1.27M29.57%-1.58M5.25%-7.79M-10.21%-1.99M15.89%-1.69M16.36%-1.87M-3.19%-2.24M
Basic earnings per share 89.95%-2.8188.74%-0.802784.54%-0.9486.14%-0.9374.63%-2.0411.04%-27.97-12.11%-7.1315.56%-6.0821.24%-6.7116.25%-8.04
Diluted earnings per share 89.95%-2.8188.74%-0.802784.54%-0.9486.14%-0.9374.63%-2.0411.04%-27.97-12.11%-7.1315.56%-6.0821.24%-6.7116.25%-8.04
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina Show More
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Unlock Now
U.S. Crypto Concept Stocks U.S. Crypto Concept Stocks

Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data. Companies involved in the creation, trade, and services of digital forms of money.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners.Displayed third-party logos, brands, or trademark images on screens or web pages are only for identification purposes and remain the property of their respective owners. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S. Crypto Concept Stocks, ranked from highest to lowest based on real-time market data.

Unlock Now